To assess the poor humoral and T-cell response to two-dose SARS-COV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
Latest Information Update: 19 Aug 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 19 Aug 2021 New trial record
- 01 Aug 2021 Results published in the Clinical Research in Cardiology